Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.
Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.
Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.
Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
Therefore, have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Survival is extended by a new treatment option for metastatic colorectal cancer.
2.
Six breast texture patterns linked to higher risk of invasive cancer
3.
New policy review highlights the importance of health-related quality of life in advanced cancer
4.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
5.
Climate change is expected to increase the number of suicide deaths
1.
Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment
2.
Exploring Innovative Approaches to Esophageal Cancer Treatment
3.
How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?
4.
Exploring the Latest Advances in PTLD Cancer Treatment
5.
The Danger of Rectus Sheath Hematoma: A Hidden Risk of Abdominal Surgery
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation